Comparison the treatment effect of Pioglithazone with Metformin in patients withNon Alcoholic SteatoHepatitis (NASH)
Phase 2
- Conditions
- Fatty liver.fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT201105026361N1
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
All patients with fatty liver disease based on sonography that have Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) more than normal (more than 40). Exclusion criteria: Alcohol consumption; drug induced hepatitis; use of some drugs (corticosteroids, statins); Diabetes mellitus; Chronic viral hepatitis (B,C); Autoimmune hepatitis; Wilson disease; Hemochromatosis; Ischemic heart disease; Heart failure; Liver failure; liver mass; Pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method